Aldehyde Dehydrogenase 1 and Raf Kinase Inhibitor Protein Expression Defines the Proliferative Nature of Cervical Cancer Stem Cells
Purpose: To determine the differences in response following the use of aldehyde dehydrogenase 1 (ALDH1) and Raf kinase inhibitor protein (RKIP) as cervical cancer stem cell markers. Methods: To evaluate the cancer stem cell markers, a mouse model with low and high grade cervical cancer was developed...
Saved in:
Published in | Tropical journal of pharmaceutical research Vol. 15; no. 1; p. 47 |
---|---|
Main Authors | , , , , , |
Format | Journal Article |
Language | English |
Published |
Pharmacotherapy Group, Faculty of Pharmacy, University of Benin, Benin City, Nigeria
01.01.2016
|
Subjects | |
Online Access | Get full text |
Cover
Loading…
Summary: | Purpose: To determine the differences in response following the use of
aldehyde dehydrogenase 1 (ALDH1) and Raf kinase inhibitor protein
(RKIP) as cervical cancer stem cell markers. Methods: To evaluate the
cancer stem cell markers, a mouse model with low and high grade
cervical cancer was developed and studied by histological examination.
Immunohistochemical and Western blotting techniques were employed to
study the expression profiles of ALDH1 and RKIP. The specificity of
Sox2 that determines cancer stem cells served as control to validate
ALDH1 and RKIP expressions. Results: Histological data helped to
differentiate low from high grade cervical cancer. The results from
immunohistochemistry show increased pattern of Sox2 expression as
tumour progresses. Similarly, ALDH1, a protein that positively
regulates stem cells shows mild expression in low grade cervical
tumour, but positive signals are more amplified in an aggressive stage
of tumour condition when compared with Sox2. The expression study with
RKIP, a protein that negatively regulates stem cells, interestingly
defines the higher expression in low grade cervical cancer to regulate
the tumour, but shows little or no very mild expression in the
aggressive stage of tumour. All the data obtained show a statistically
significant value of p < 0.05. The results with Immunohistochemistry
were further validated using the western blotting analysis and it also
confirms the similar results. Conclusion: ALDH1 and RKIP marker in
association correlation with Sox2 aids in defining the proliferative
ability of cervical cancer stem cells and also to validate them in
initial and advanced stages of cervical cancer. |
---|---|
ISSN: | 1596-5996 1596-9827 |
DOI: | 10.4314/tjpr.v15i1.7 |